Proposal: trauma as the cause of the Peyronie's lesion

scientific article published in January 1997

Proposal: trauma as the cause of the Peyronie's lesion is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00005392-199701000-00098
P698PubMed publication ID8976281

P2093author name stringS G Jordan
C J Devine
S M Schlossberg
K D Somers
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)285-290
P577publication date1997-01-01
P1433published inJournal of UrologyQ15709979
P1476titleProposal: trauma as the cause of the Peyronie's lesion
P478volume157

Reverse relations

cites work (P2860)
Q84949257A novel modification of tunical plication by plaque thinning: long-term results in treating penile curvature of Peyronie's disease
Q26747269A review of the epidemiology and treatment of Peyronie's disease
Q35738222Activin Receptor-Like Kinase 5 Inhibitor Attenuates Fibrosis in Fibroblasts Derived from Peyronie's Plaque
Q90578336Advances in stem cell therapy for the treatment of Peyronie's disease
Q54957145All about Peyronie's disease.
Q30458422Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?
Q41487802Clinical and epidemiological characteristics of young patients with Peyronie's disease: a retrospective study
Q35604418Effect of SMAD7 gene overexpression on TGF-β1-induced profibrotic responses in fibroblasts derived from Peyronie's plaque
Q46130680Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study
Q41909374Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases.
Q46936674Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease.
Q43099012Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study
Q91649266Evolving therapies for Peyronie's disease: how can we work towards new drugs?
Q30857029Experience in the use of collagenase clostridium histolyticum in the management of Peyronie's disease: current data and future prospects
Q52991896Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease.
Q36395176Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease
Q91649258Minimally invasive therapies for Peyronie's disease: the current state of the art
Q35947455New discoveries in the basic science understanding of Peyronie's disease
Q38568077PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.
Q80297464Penile prosthesis implantation for end-stage erectile dysfunction after radical prostatectomy
Q80296018Peyronie's Disease: A Review
Q38901773Peyronie's Disease: Intralesional Therapy and Surgical Intervention
Q42111574Peyronie's disease after urethral swab, an unusual complication: a case report
Q45961053Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque.
Q26768640Peyronie's disease: What's around the bend?
Q40318948Peyronie's disease: a difficult sexual dysfunction problem.
Q26746145Peyronie's disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up
Q36082087Peyronie's disease: the epidemiology, aetiology and clinical evaluation of deformity
Q36757584Pharmacological Management of Peyronie's Disease
Q55349667Prospective study to evaluate the clinical outcome of intralesional interferon-α2b in the management of Peyronie's disease.
Q41149177Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application
Q38661272Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment-Literature Review.
Q37325500Review of the surgical approaches for Peyronie's disease: corporeal plication and plaque incision with grafting
Q46936661Risk factors for Peyronie's disease: a case-control study.
Q34061326Role of the HLA System in the Pathogenesis of Dupuytren's Disease.
Q54090838Silencing Histone Deacetylase 7 Alleviates Transforming Growth Factor-β1-Induced Profibrotic Responses in Fibroblasts Derived from Peyronie's Plaque.
Q50050957Sonographic patterns of Peyronie's disease in patients with absence of palpable plaques
Q38908920Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease.
Q35914222Surgical alternatives for treating Peyronie's disease
Q38794101Surgical treatment of Peyronie's disease with small intestinal submucosa graft patch.
Q36651563The Genetic Basis of Peyronie's Disease: A Review.
Q35933254The Prevalence of Peyronie's Disease in the United States: A Population-Based Study
Q41830691The Therapeutic Effects of Intracavernosal Plaque Excision in Peyronie's Disease: A None Grafting or Tunical Excising Procedure
Q46508636The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease.
Q47162651The histopathological effects of intracavernosal mitomycin-C injection in a rat Peyronie's disease model
Q42576277The pathophysiology of Peyronie's disease: beyond the Smith's space
Q42180966The role of intrinsic pathway in apoptosis activation and progression in Peyronie's disease
Q35116422The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets
Q37704966Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy
Q30459971US Imaging in Peyronie's Disease
Q37500114Urologists' Perceptions and Practice Patterns in Peyronie's Disease: A Korean Nationwide Survey Including Patient Satisfaction

Search more.